There are weekly injectables currently, and more in development
N., Finnie, J
As a research compound, AOD9604 UK carries a well-characterised pre-clinical and early-phase clinical research profile developed primarily through the work of Metabolic Pharmaceuticals, with published studies spanning lipid metabolism, adipose biology, 3-adrenergic receptor regulation, cartilage biology, and safety pharmacology
Can lifestyle factors affect my glutathione levels
Now, a research team known for inventing the first GLP-1-GIP combination agonist has linked that peptide to a ligand for another target that is also hotly pursued in metabolic disease
Possible monitoring points include product quality, dosing accuracy, unknown long-term safety, and limited human evidence for routine wellness use